Benefits of Self-Esteem
Tumor Immunotherapy
Predicting Molecular Geometry
Prediction Intervals
Sensitivity, Specificity, and Predicted Value
End Point Prediction: Gran Plot
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 11, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
The first phase III CheckMate-227 trial data shows ipilimumab plus nivolumab improves progression-free survival in non-small cell lung cancer patients with high tumor mutation burden. This immunotherapy combination demonstrated superior outcomes compared to chemotherapy.
Area of Science:
Background: